Monday, December 9, 2024

CATEGORY

Health Economics

Enhancing CAR T-Cell Therapy through Patient-Centered Approaches

A groundbreaking advancement in hematology has been the introduction of chimeric antigen receptor (CAR) T-cell therapy, markedly improving survival rates among those battling hematological...

EUCOPE and FTI Consulting Propel EU Life Sciences Investment

On November 14th, EUCOPE and FTI Consulting EU convened a pivotal event titled What Drives Life Sciences Investment in the EU and the Future...

China’s Path to Coordinating Environmental and Health Advancements

In an era where industrial technology accelerates at an unprecedented pace, the intersection of environmental change and public health has become a pressing concern...

Extended School Commutes Adversely Affect Thai Students’ Health

Thai students face significant challenges when commuting to school, which potentially impacts their health. A comprehensive study comprising 25,461 students aged 9 to 18...

New Antibiotic EXBLIFEP Targets Resistant Bacterial Infections

Key TakeawaysEXBLIFEP addresses a critical gap in treating antibiotic-resistant infections. Cost-effectiveness may vary based on infection severity and patient demographics. Strict usage guidelines...

Prevention and Screening Lead in Reducing Cancer Deaths Across Five Major Types

Key TakeawaysPrevention and screening are more effective than treatment alone in reducing mortality for most studied cancers. Smoking cessation remains the most impactful...

Pharmaceutical Industry Raises Alarm Over Limited EU HTA Consultation Slots for 2025

Key TakeawaysOver 50 products may require JSCs in 2025, far exceeding the planned 5-7 slots. Small to mid-sized companies, which are pivotal in...

G-BA Confirms Unrestricted Access to Marstacimab for Hemophilia Patients

Key TakeawaysHealthcare providers can streamline the distribution of Marstacimab. Patients may experience quicker access to necessary treatments. The decision may reduce bureaucratic overhead...

German Health Committee Assesses Cefepime/Enmetazobactam for Severe Infections

Key TakeawaysEstimated patient population indicates a moderate demand within the GKV system. Cost analysis highlights significant financial considerations for widespread adoption. Reserve antibiotic...

Germany Enforces Stricter Recruitment Standards for Pharma Studies

Key TakeawaysEnsures studies reflect the German patient population Enhances the relevance of clinical trial data for the local market May increase the administrative...

Revisiting Rehabilitation: Cancer Patients and Access to Inpatient Facilities

Inpatient rehabilitation facilities (IRFs) play a pivotal role in enhancing the functionality of individuals requiring post-acute care. Despite their potential benefits, particularly for cancer...

Global Health Report Highlights Market Access Challenges

In a world increasingly interconnected through trade and commerce, market access remains a pivotal topic, especially within the global health sector. The recent article...

NICE Launches Targeted Rollout of Tirzepatide for Severe Obesity

Key Takeaways • Tirzepatide demonstrated a 21% average body weight reduction in clinical trials. • The initial rollout is expected to benefit around 220,000 people. • NHS...

Europe Urges Strategic Moves to Boost Biosimilar Medicine Impact

Europe stands at a pivotal moment as biologic drugs approach the end of their market exclusivity, presenting a significant opportunity to enhance healthcare access...

2021 Data Shows Increasing Maternal Health Disparities in Medicaid and CHIP

The latest Maternal Health Equity Data Brief reveals concerning trends in maternal health among Medicaid and CHIP enrollees aged 15 to 49. Analyzing data...

Latest news